Which has higher valuation and earnings, CTEV or SDGR?

Schrodinger has lower revenue, but higher earnings than Claritev. Schrodinger is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Claritev $965.41M 0.74 -$284.28M -$17.01 N/A Schrodinger $255.87M 5.33 -$103.26M -$0.74 N/A

Is CTEV or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Claritev -28.46% N/A -5.72% Schrodinger -20.98% -16.37% -8.19%

Does the media favor CTEV or SDGR?

In the previous week, Claritev had 17 more articles in the media than Schrodinger. MarketBeat recorded 25 mentions for Claritev and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.69 beat Claritev's score of 0.41 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 4 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, GDRX or CTEV?

GoodRx has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.60 $30.44M $0.04 93.00 Claritev $965.41M 0.74 -$284.28M -$17.01 N/A

Is GDRX or CTEV more profitable?

GoodRx has a net margin of 2.07% compared to Claritev's net margin of -28.46%. GoodRx's return on equity of 7.22% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Claritev -28.46% N/A -5.72%

Does the media prefer GDRX or CTEV?

In the previous week, Claritev had 10 more articles in the media than GoodRx. MarketBeat recorded 25 mentions for Claritev and 15 mentions for GoodRx. GoodRx's average media sentiment score of 0.73 beat Claritev's score of 0.41 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Claritev 4 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, CERT or CTEV?

Certara has higher earnings, but lower revenue than Claritev. Certara is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.97 -$1.60M -$0.45 N/A Claritev $965.41M 0.74 -$284.28M -$17.01 N/A

Is CERT or CTEV more profitable?

Certara has a net margin of -16.75% compared to Claritev's net margin of -28.46%. Certara's return on equity of 3.86% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Claritev -28.46% N/A -5.72%

Does the media refer more to CERT or CTEV?

In the previous week, Claritev had 15 more articles in the media than Certara. MarketBeat recorded 25 mentions for Claritev and 10 mentions for Certara. Certara's average media sentiment score of 1.10 beat Claritev's score of 0.41 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Claritev 4 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, TDOC or CTEV?

Teladoc Health has higher revenue and earnings than Claritev. Teladoc Health is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teladoc Health $2.53B 0.50 -$200.32M -$0.99 N/A Claritev $965.41M 0.74 -$284.28M -$17.01 N/A

Does the media refer more to TDOC or CTEV?

In the previous week, Claritev had 15 more articles in the media than Teladoc Health. MarketBeat recorded 25 mentions for Claritev and 10 mentions for Teladoc Health. Claritev's average media sentiment score of 0.41 beat Teladoc Health's score of 0.02 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 1 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Claritev 4 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, CTEV or HSTM?

HealthStream has lower revenue, but higher earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Claritev $965.41M 0.74 -$284.28M -$17.01 N/A HealthStream $321.12M 2.64 $18.34M $0.72 40.31

Does the media favor CTEV or HSTM?

In the previous week, Claritev had 21 more articles in the media than HealthStream. MarketBeat recorded 25 mentions for Claritev and 4 mentions for HealthStream. HealthStream's average media sentiment score of 1.05 beat Claritev's score of 0.41 indicating that HealthStream is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 4 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HealthStream 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Claritev (CTEV) Competitors

$41.73 +6.41 (+18.15%)

As of 03:58 PM Eastern

Compare

CTEV vs. SDGR, GDRX, CERT, TDOC, and HSTM

Should you buy Claritev stock or one of its competitors? Claritev's main competitors and comparable companies include Schrodinger (SDGR), GoodRx (GDRX), Certara (CERT), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Claritev compare to Schrodinger?

Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Claritev has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market.

Schrodinger has a net margin of -20.98% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.72%
Schrodinger	-20.98%	-16.37%	-8.19%

87.2% of Claritev shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 7.4% of Claritev shares are owned by company insiders. Comparatively, 10.1% of Schrodinger shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Claritev currently has a consensus price target of $42.83, indicating a potential upside of 2.64%. Schrodinger has a consensus price target of $20.25, indicating a potential upside of 9.70%. Given Schrodinger's higher possible upside, analysts plainly believe Schrodinger is more favorable than Claritev.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	2 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.44
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Schrodinger has lower revenue, but higher earnings than Claritev. Schrodinger is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.74	-$284.28M	-$17.01	N/A
Schrodinger	$255.87M	5.33	-$103.26M	-$0.74	N/A

In the previous week, Claritev had 17 more articles in the media than Schrodinger. MarketBeat recorded 25 mentions for Claritev and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.69 beat Claritev's score of 0.41 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Claritev and Schrodinger tied by winning 8 of the 16 factors compared between the two stocks.

How does Claritev compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Claritev had 10 more articles in the media than GoodRx. MarketBeat recorded 25 mentions for Claritev and 15 mentions for GoodRx. GoodRx's average media sentiment score of 0.73 beat Claritev's score of 0.41 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	3 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GoodRx presently has a consensus price target of $4.14, suggesting a potential upside of 11.19%. Claritev has a consensus price target of $42.83, suggesting a potential upside of 2.64%. Given GoodRx's higher possible upside, equities research analysts plainly believe GoodRx is more favorable than Claritev.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Claritev	2 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.44

GoodRx has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.60	$30.44M	$0.04	93.00
Claritev	$965.41M	0.74	-$284.28M	-$17.01	N/A

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 7.4% of Claritev shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GoodRx has a net margin of 2.07% compared to Claritev's net margin of -28.46%. GoodRx's return on equity of 7.22% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Claritev	-28.46%	N/A	-5.72%

GoodRx has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Claritev has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

Summary

GoodRx beats Claritev on 10 of the 16 factors compared between the two stocks.

How does Claritev compare to Certara?

Certara (NASDAQ:CERT) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

Certara has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market. Comparatively, Claritev has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Certara currently has a consensus target price of $8.28, suggesting a potential upside of 1.57%. Claritev has a consensus target price of $42.83, suggesting a potential upside of 2.64%. Given Claritev's stronger consensus rating and higher probable upside, analysts plainly believe Claritev is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Claritev	2 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.44

Certara has a net margin of -16.75% compared to Claritev's net margin of -28.46%. Certara's return on equity of 3.86% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Claritev	-28.46%	N/A	-5.72%

74.0% of Certara shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 7.4% of Claritev shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Claritev had 15 more articles in the media than Certara. MarketBeat recorded 25 mentions for Claritev and 10 mentions for Certara. Certara's average media sentiment score of 1.10 beat Claritev's score of 0.41 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has higher earnings, but lower revenue than Claritev. Certara is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.97	-$1.60M	-$0.45	N/A
Claritev	$965.41M	0.74	-$284.28M	-$17.01	N/A

Summary

Certara beats Claritev on 9 of the 17 factors compared between the two stocks.

How does Claritev compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

Teladoc Health has higher revenue and earnings than Claritev. Teladoc Health is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.50	-$200.32M	-$0.99	N/A
Claritev	$965.41M	0.74	-$284.28M	-$17.01	N/A

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 7.4% of Claritev shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Teladoc Health has a beta of 2.12, meaning that its stock price is 112% more volatile than the broader market. Comparatively, Claritev has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

Teladoc Health has a net margin of -7.13% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
Claritev	-28.46%	N/A	-5.72%

In the previous week, Claritev had 15 more articles in the media than Teladoc Health. MarketBeat recorded 25 mentions for Claritev and 10 mentions for Teladoc Health. Claritev's average media sentiment score of 0.41 beat Teladoc Health's score of 0.02 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	1 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Teladoc Health presently has a consensus target price of $7.54, suggesting a potential upside of 8.63%. Claritev has a consensus target price of $42.83, suggesting a potential upside of 2.64%. Given Teladoc Health's higher possible upside, equities analysts clearly believe Teladoc Health is more favorable than Claritev.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
Claritev	2 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.44

Summary

Claritev beats Teladoc Health on 10 of the 16 factors compared between the two stocks.

How does Claritev compare to HealthStream?

Claritev (NYSE:CTEV) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

Claritev has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

87.2% of Claritev shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 7.4% of Claritev shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Claritev had 21 more articles in the media than HealthStream. MarketBeat recorded 25 mentions for Claritev and 4 mentions for HealthStream. HealthStream's average media sentiment score of 1.05 beat Claritev's score of 0.41 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthStream	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthStream has a net margin of 6.60% compared to Claritev's net margin of -28.46%. HealthStream's return on equity of 6.81% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.72%
HealthStream	6.60%	6.81%	4.64%

HealthStream has lower revenue, but higher earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.74	-$284.28M	-$17.01	N/A
HealthStream	$321.12M	2.64	$18.34M	$0.72	40.31

Claritev presently has a consensus target price of $42.83, indicating a potential upside of 2.64%. HealthStream has a consensus target price of $27.00, indicating a potential downside of 6.96%. Given Claritev's stronger consensus rating and higher probable upside, equities research analysts plainly believe Claritev is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	2 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.44
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

HealthStream beats Claritev on 9 of the 16 factors compared between the two stocks.

Get Claritev News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEV vs. The Competition

Export

Metric	Claritev	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$711.50M	$1.62B	$7.03B	$24.28B
Dividend Yield	N/A	4.70%	2.58%	3.70%
P/E Ratio	-2.45	24.33	270.65	30.41
Price / Sales	0.74	74.36	641.14	18.37
Price / Cash	2.26	30.37	70.59	33.27
Price / Book	-4.13	6.46	13.24	6.68
Net Income	-$284.28M	-$25.90M	$3.45B	$1.06B
7 Day Performance	56.41%	7.02%	2.03%	1.35%
1 Month Performance	38.87%	5.39%	1.07%	3.24%
1 Year Performance	-36.48%	-14.48%	67.58%	17.33%

Claritev Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEV Claritev	2.1646 of 5 stars	$41.73 +18.1%	$42.83 +2.6%	-43.1%	$711.50M	$965.41M	N/A	3,000	News Coverage Analyst Forecast Insider Trade
SDGR Schrodinger	1.2031 of 5 stars	$18.16 +2.0%	$20.25 +11.5%	-1.2%	$1.31B	$255.87M	N/A	790
GDRX GoodRx	3.8411 of 5 stars	$3.68 -1.1%	$4.15 +12.7%	+2.6%	$1.27B	$796.85M	92.02	950	News Coverage Analyst Forecast Gap Up
CERT Certara	2.0113 of 5 stars	$8.20 +0.9%	$8.28 +0.9%	-25.5%	$1.24B	$418.84M	N/A	1,576	Gap Up
TDOC Teladoc Health	2.6478 of 5 stars	$7.12 +6.5%	$7.54 +5.9%	-2.5%	$1.21B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CTEV) was last updated on 8/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Claritev (CTEV) Competitors

CTEV vs. SDGR, GDRX, CERT, TDOC, and HSTM

How does Claritev compare to Schrodinger?

Summary

How does Claritev compare to GoodRx?

Summary

How does Claritev compare to Certara?

Summary

How does Claritev compare to Teladoc Health?

Summary

How does Claritev compare to HealthStream?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEV vs. The Competition

Claritev Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Claritev (CTEV) Competitors

CTEV vs. SDGR, GDRX, CERT, TDOC, and HSTM

How does Claritev compare to Schrodinger?

Which has more volatility and risk, CTEV or SDGR?

Is CTEV or SDGR more profitable?

Do institutionals & insiders believe in CTEV or SDGR?

Do analysts rate CTEV or SDGR?

Which has higher valuation and earnings, CTEV or SDGR?

Does the media favor CTEV or SDGR?

Summary

How does Claritev compare to GoodRx?

Does the media prefer GDRX or CTEV?

Do analysts prefer GDRX or CTEV?

Which has preferable valuation and earnings, GDRX or CTEV?

Do insiders & institutionals hold more shares of GDRX or CTEV?

Is GDRX or CTEV more profitable?

Which has more volatility & risk, GDRX or CTEV?

Summary

How does Claritev compare to Certara?

Which has more volatility & risk, CERT or CTEV?

Do analysts prefer CERT or CTEV?

Is CERT or CTEV more profitable?

Do institutionals & insiders believe in CERT or CTEV?

Does the media refer more to CERT or CTEV?

Which has stronger earnings and valuation, CERT or CTEV?

Summary

How does Claritev compare to Teladoc Health?

Which has better earnings and valuation, TDOC or CTEV?

Do insiders and institutionals hold more shares of TDOC or CTEV?

Which has more risk and volatility, TDOC or CTEV?

Is TDOC or CTEV more profitable?

Does the media refer more to TDOC or CTEV?

Do analysts rate TDOC or CTEV?

Summary

How does Claritev compare to HealthStream?

Which has more volatility and risk, CTEV or HSTM?

Do insiders & institutionals believe in CTEV or HSTM?

Does the media favor CTEV or HSTM?

Is CTEV or HSTM more profitable?

Which has preferable valuation and earnings, CTEV or HSTM?

Do analysts recommend CTEV or HSTM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEV vs. The Competition

Claritev Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools